US 12049471
Cyano cyclobutyl compounds for Cbl-b inhibition and uses thereof
granted A61PA61P35/00A61P37/00
Quick answer
US patent 12049471 (Cyano cyclobutyl compounds for Cbl-b inhibition and uses thereof) held by NURIX THERAPEUTICS, INC. expires Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- NURIX THERAPEUTICS, INC.
- Grant date
- Tue Jul 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61P, A61P35/00, A61P37/00